Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

• Status: Not yet recruiting
• Trial end date: 2024-06-30
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the effectiveness of applying Hypertonic Saline solution directly on the Melanomas in reducing their sizes and/or number.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rafik Batroussy

Criteria

Inclusion Criteria:

• Patients with clinically-confirmed Melanoma (any location and any stage) who have poorly responded to at least one cycle of conventional and standard therapy (Chemotherapy, Radiation or Drug therapy).

• Age 5 to 80 years old

• Life expectancy of at least 1 year

• Can understand and read English

• Lives in USA.

Patient who do not meet the Inclusion Criteria but still wish to participate will be accepted as Observational participants, but their Melanoma measurements will be not be taken into account when analyzing the Study statistically.

Exclusion Criteria:

• Skin eczema and/or other skin conditions contraindicated to skin dehydration.

• Ulcers or open wounds close to Melanoma

• Any medical condition that might cause the patient to lose consciousness

• Participants who are not residents of USA.